The patient simulators market is expected to grow from US$ 1,599.41 million in 2021 to US$ 4,284.03 million by 2028; it is estimated to register a CAGR of 15.2% from 2022 to 2028.

The market growth is attributed to the growing use of patient simulators for training purposes and the increasing demand for minimally invasive treatment methods. However, the high cost of patient simulators hampers the market growth.

A patient simulator is a manikin that mimics human anatomy or function (physiology), which can be used to train students and healthcare professionals. Clinical simulation allows practitioners of all levels and healthcare disciplines to practice and improve their clinical skills without any potential harm to patients. Patient simulators are most frequently used in academic institutions, academic medical centers, government research organizations, hospitals & clinics, and military training centers.

Growing Technological Advancements in Patient Simulators
There have been rapid advancements in healthcare technologies over the last few decades with the emergence of technologies such as virtual reality, augmented reality, artificial intelligence, robotics, 3D printing, and nanotechnology, and these will continue to shape the future of healthcare in the years to come. Advanced technology has made it possible that computer software can be integrated into manikins. The organs of one of these lifelike medical simulators, including their heart, blood vessels, lungs, and gastrointestinal tract, can also be made to respond to various human interventions during clinical simulation engagements. The computer software allows human patient simulators to replicate normal and abnormal bodily responses for educational and training purposes. Often these responses are initiated by several physical events, such as an asthma attack. Therapeutic interventions can also be replicated under certain circumstances, including representing a side effect of a medication.

More advanced simulators allow learners to use mixed reality viewer lenses to visualize the internal anatomy of a simulated patient. With these lenses, students can learn skills through observation and remote active participation. For instance, Gaumard’s most advanced product combines mixed reality technology with a high-fidelity birthing simulator. With mixed reality goggles, a learner can visualize the baby and cardinal movements during decent while engaging in the hands-on exercise of delivering the baby. In the event of a complication, the learner can observe the mother’s and baby’s anatomy. Suppose the baby is not descending through the birth canal. In that case, learners can now manipulate the simulator in a specific way and receive visual feedback indicating that their legs have been moved to the proper position. With patient simulators, learners can practice these skills repeatedly to gain the muscle memory and critical thinking skills needed to react quickly during complicated procedures.

Thus, the growing technological advancement in simulation is expected to introduce new trends to the patient simulators market.
The patient simulators market in North America holds the largest share. The market growth in the region is attributed to the rising preference for patient simulators in nursing education and the availability of better healthcare facilities. In North America, the US is the largest market for patient simulators. In order to reduce the number of medical errors, the focus on providing medical education by using patient simulators has significantly increased in the US. Various manufacturers and training organizations have been offering training with the use of their patient simulators. For instance, The Johns Hopkins Medicine Simulation Center is a fully accredited state-of-the-art medical training facility that incorporates various types of simulation, including standardized patients and teaching associates, human patient simulation, virtual reality, task trainers, and computerized simulation. The primary goal of the center is to improve safety within patient care. These training centers not only help improve patient safety but also increase a clinician’s comfort and response to an emergency situation.

Canada holds the second-largest share of the patient simulators market in North America. There have been various initiatives in Canada to promote the growth of the patient simulators market. Canada hosts a number of nonprofit institutes and organizations that work in the field of patient simulators. SIM-one—the Ontario Simulation Network—is a not-for-profit organization that connects the simulation community, as well as simulation facilities, resources, and services across Ontario. It also promotes and advances simulated learning in the health professions. SIM-one is fully supported by Ontario’s Ministry of Health and Long-term Care.
The World Health Organization (WHO), National Library of Medicine, and whitepapers are among the secondary sources referred to while preparing the report on the patient simulators market.

TABLE OF CONTENTS

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Patient Simulators Market – By Product
1.3.2 Global Patient Simulators Market – By End User
1.3.3 Global Patient Simulators Market – By Geography
2. Patient Simulators Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Patient Simulators Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Patient Simulators Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Use of Patient Simulators for Training Purposes
5.1.2 Increase in Demand for Minimally Invasive Treatment Methods
5.2 Market Restraints
5.2.1 High Cost of Patient Simulators
5.3 Market Opportunities
5.3.1 Rising Awareness of Simulation Education
5.4 Future Trends
5.4.1 Growing Technological Advancements in Patient Simulators
5.5 Impact Analysis
6. Patient Simulators Market – Global Analysis
6.1 Global Patient Simulators Market Revenue Forecast and Analysis
6.2 Global Patient Simulators Market, by Geography – Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Patient Simulators Market – Revenue and Forecast to 2028 – by Product
7.1 Overview
7.2 Patient Simulators Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Adult Patient Simulators
7.3.1 Overview
7.3.2 Adult Patient Simulators: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Infant Simulators
7.4.1 Overview
7.4.2 Infant Simulators: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Childbirth Simulators
7.5.1 Overview
7.5.2 Childbirth Simulators: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Patient Simulators Market Analysis and Forecasts to 2028 – by End User
8.1 Overview
8.2 Global Patient Simulators Market, by End User 2021 & 2028 (%)
8.3 Academic Institutes
8.3.1 Overview
8.3.2 Academic Institutes: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Hospitals
8.4.1 Overview
8.4.2 Hospitals: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Military Organizations
8.5.1 Overview
8.5.2 Military Organizations: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9. Patient Simulators Market – Revenue and Forecast to 2028 – Geographic Analysis
9.1 North America: Patient Simulators Market
9.1.1 Overview
9.1.2 North America: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3 North America: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.1.4 North America: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.1.4.1 US: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.1.1 Overview
9.1.4.1.2 US: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.1.3 US: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.1.4.1.4 US: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.1.4.2 Canada Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.2.1 Overview
9.1.4.2.2 Canada: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.2.3 Canada: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.1.4.2.4 Canada: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.1.4.3 Mexico: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.3.1 Overview
9.1.4.3.2 Mexico: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.3.3 Mexico: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.1.4.3.4 Mexico: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.2 Europe: Patient Simulators Market
9.2.1 Overview
9.2.2 Europe: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.2.3 Europe: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.2.4 Europe: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.2.5 Europe: Patient Simulators Market, by Country, 2021 & 2028 (%)
9.2.5.1 Germany: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.1 Overview
9.2.5.1.2 Germany: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.3 Germany: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.2.5.1.4 Germany: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.2.5.2 UK: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.1 Overview
9.2.5.2.2 UK: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.3 UK: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.2.5.2.4 UK: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.2.5.3 France: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 Overview
9.2.5.3.2 France: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.3 France: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.2.5.3.4 France: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.2.5.4 Italy: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.1 Overview
9.2.5.4.2 Italy: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.3 Italy: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.2.5.4.4 Italy: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.2.5.5 Spain: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 Overview
9.2.5.5.2 Spain: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.3 Spain: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.2.5.5.4 Spain: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.2.5.6 Rest of Europe: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Overview
9.2.5.6.2 Rest of Europe: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.3 Rest of Europe: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.2.5.6.4 Rest of Europe: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.3 Asia Pacific: Patient Simulators Market
9.3.1 Overview
9.3.2 Asia Pacific: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.3.3 Asia Pacific: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.3.4 Asia Pacific: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.3.5 Asia Pacific: Patient Simulators Market, by Country, 2021 & 2028 (%)
9.3.5.1 China: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.1 Overview
9.3.5.1.2 China: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.1.3 China: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.3.5.1.4 China: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.3.5.2 Japan: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.1 Overview
9.3.5.2.2 Japan: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.2.3 Japan: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.3.5.2.4 Japan: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.3.5.3 India: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.1 Overview
9.3.5.3.2 India: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.3.3 India: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.3.5.3.4 India: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.3.5.4 Australia: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.1 Overview
9.3.5.4.2 Australia: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.4.3 Australia: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.3.5.4.4 Australia: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.3.5.5 South Korea: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.1 Overview
9.3.5.5.2 South Korea: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.5.3 South Korea: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.3.5.5.4 South Korea: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.3.5.6 Rest of Asia Pacific: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.1 Overview
9.3.5.6.2 Rest of Asia Pacific: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.3 Rest of Asia Pacific: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.3.5.6.4 Rest of Asia Pacific: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.4 Middle East & Africa Patient Simulators Market
9.4.1 Overview
9.4.2 Middle East & Africa: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.4.3 Middle East & Africa: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.4.4 Middle East & Africa Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.4.4.1 South Africa: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.1.1 Overview
9.4.4.1.2 South Africa: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.1.3 South Africa: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.4.4.1.4 South Africa Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.4.4.2 Saudi Arabia: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.2.1 Overview
9.4.4.2.2 Saudi Arabia: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.2.3 Saudi Arabia: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.4.4.2.4 Saudi Arabia Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.4.4.3 UAE: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.3.1 Overview
9.4.4.3.2 UAE: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.3.3 UAE: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.4.4.3.4 UAE Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.4.4.4 Rest of Middle East & Africa: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.4.1 Overview
9.4.4.4.2 Rest of Middle East & Africa: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.4.3 Rest of Middle East & Africa: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.4.4.4.4 Rest of Middle East & Africa Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.5 South & Central America Patient Simulators Market
9.5.1 Overview
9.5.2 South & Central America: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.5.3 South & Central America: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.5.4 South & Central America: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.5.5 South & Central America: Patient Simulators Market, by Country, 2021 & 2028 (%)
9.5.5.1 Brazil: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.1.1 Overview
9.5.5.1.2 Brazil: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.1.3 Brazil: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.5.5.1.4 Brazil: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.5.5.2 Argentina: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.2.1 Overview
9.5.5.2.2 Argentina: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.2.3 Argentina: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.5.5.2.4 Argentina: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
9.5.5.3 Rest of South & Central America: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.1 Overview
9.5.5.3.2 Rest of South & Central America: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.3 Rest of South & Central America: Patient Simulators Market, by Product, 2019–2028 (US$ Million)
9.5.5.3.4 Rest of South & Central America: Patient Simulators Market, by End User, 2019–2028 (US$ Million)
10. Impact Of COVID-19 Pandemic on Patient Simulators Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
10.5 South & Central America: Impact Assessment of COVID-19 Pandemic
11. Patient Simulators Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Patient Simulators Market (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 CAE Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Laerdal Medical AS
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Gaumard Scientific Co Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Kyoto Kagaku Co Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Surgical Science Sweden AB
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Simulab Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Simulaids Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Mentice AB
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Limbs & Things Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 VirtaMed AG
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 3. US Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 4. US Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Canada Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. Mexico Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Europe Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 10. Europe Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Germany Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 12. Germany Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. UK Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 14. UK Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 15. France Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 16. France Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Italy Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 19. Spain Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Rest of Europe Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 23. Asia Pacific Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 24. Asia Pacific Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 25. China Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 26. China Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 27. Japan Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 28. Japan Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 29. India Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 30. India Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 31. Australia Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 32. Australia Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 33. South Korea Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 34. South Korea Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Asia Pacific Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Asia Pacific Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 37. Middle East & Africa Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 38. Middle East & Africa Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 39. South Africa Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 40. South Africa Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 41. Saudi Arabia Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 42. Saudi Arabia Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 43. UAE Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 44. UAE Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of Middle East & Africa Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 46. Rest of Middle East & Africa Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 47. South & Central America Patient Simulators Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 48. South & Central America Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 49. Brazil Patient Simulators Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 50. Brazil Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 51. Argentina Patient Simulators Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 52. Argentina Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 53. Rest of South & Central America Patient Simulators Market, by Product– Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of South & Central America Patient Simulators Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 55. Organic Developments in the Patient Simulators Market
Table 56. Inorganic Developments in the Patient Simulators Market
Table 57. Glossary of Terms

LIST OF FIGURES

Figure 1. Patient Simulators Market Segmentation
Figure 2. Patient Simulators Market – By Geography
Figure 3. Patient Simulators Market Overview
Figure 4. Adult Patient Simulator Segment Held Largest Share by Product of Patient Simulators Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Patient Simulators Market, by Geography (US$ Million)
Figure 7. Global Patient Simulators Market – Leading Country Markets (US$ Million)
Figure 8. Global Patient Simulators Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Patient Simulators Market: Impact Analysis of Drivers and Restraints
Figure 16. Global Patient Simulators Market – Revenue Forecast and Analysis – 2020–2028
Figure 17. Global Patient Simulators Market, by Geography – Forecast and Analysis (2021–2028)
Figure 18. Market Positioning of Key Players in Patient Simulators Market
Figure 19. Patient Simulators Market Revenue Share, by Product 2021 & 2028 (%)
Figure 20. Adult Patient Simulators: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Infant Simulators: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Childbirth Simulators: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Global Patient Simulators Market, by End User 2021 & 2028 (%)
Figure 24. Academic Institutes: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Hospitals: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Military Organizations: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. North America: Patient Simulators Market, by Key Country – Revenue (2021) (US$ Million)
Figure 28. North America Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America: Patient Simulators Market, by Country, 2021 & 2028 (%)
Figure 30. US: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Canada: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Mexico: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Europe: Patient Simulators Market, by Key Country – Revenue (2021) (US$ Million)
Figure 34. Europe Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Europe: Patient Simulators Market, by Country, 2021 & 2028 (%)
Figure 36. Germany: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. UK: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 38. France: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Italy: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Spain: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Rest of Europe: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Asia Pacific: Patient Simulators Market, by Key Country – Revenue (2021) (US$ Million)
Figure 43. Asia Pacific Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. China: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. Japan: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. India: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Australia: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. South Korea: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Rest of Asia Pacific: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Middle East & Africa: Patient Simulators Market, by Key Country – Revenue (2021) (US$ Million)
Figure 51. Middle East & Africa Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Middle East & Africa: Patient Simulators Market, by Country, 2021 & 2028 (%)
Figure 53. South Africa: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Saudi Arabia: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. UAE: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Rest of Middle East & Africa: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. South & Central America: Patient Simulators Market, by Key Country – Revenue (2021) (US$ Million)
Figure 58. South & Central America Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. South & Central America: Patient Simulators Market, by Country, 2021 & 2028 (%)
Figure 60. Brazil: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. Argentina: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. Rest of South & Central America: Patient Simulators Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. Impact of COVID-19 Pandemic on North American Country Markets
Figure 64. Impact of COVID-19 Pandemic on Europe Country Markets
Figure 65. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 66. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 67. Impact of COVID-19 Pandemic in South and Central America Country Markets
Figure 68. Growth Strategies in the Patient Simulators Market (%)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the patient simulators market.
● Highlights key business priorities in order to assist companies to realign their business strategies.
● The key findings and recommendations highlight crucial progressive industry trends in the global patient simulators market, thereby allowing players across the value chain to develop effective long-term strategies.
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
● Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

The List of Companies – Patient Simulators Market
● CAE Inc
● Laerdal Medical AS
● Gaumard Scientific Co Inc
● Kyoto Kagaku Co Ltd
● Surgical Science Sweden AB
● Simulab Corp
● Simulaids Ltd
● Mentice AB
● Limbs & Things Ltd
● VirtaMed AG

Adult Patient Simulators Segment to Register Highest CAGR in Patient Simulators Market During 2022–2028

According to our latest study on “Patient Simulators Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product and End User,” the market is projected to reach US$ 4,284.03 million by 2028 from US$ 1,599.41 million in 2021; it is expected to register a CAGR of 15.2% from 2022 to 2028. The report highlights the key factors driving the market and prominent players with their developments in the patient simulators market.

The COVID-19 pandemic positively impacted the global patient simulators market. The research and development for studying COVID-19 with the help of manikin have fueled the demand for patient simulators. Simulators also played a significant role in preparing medical professionals to treat COVID-19 patients. At the onset of the pandemic, the rapid escalation in cases caught many facilities and staff unprepared. Because healthcare professionals working in critical care have vastly different skillsets from those in the emergency department or the medical surgery floor, many did not have the skills to treat patients with COVID-19 properly. This resulted in increased demand for simulators and skills trainers, not only to train new providers but also to cross-train healthcare professionals from other departments who were helping to meet the demands of COVID-19. Due to the pandemic, there has been an increased reliance on robot-like patient simulators for training.

Based on product, the patient simulators market is segmented into adult patient simulator, infant simulator, and childbirth simulator. In 2021, the adult patient simulator segment held the largest market share. Also, the same segment is anticipated to register the highest CAGR during the forecast period. Based on end user, the patient simulators market is segmented into academic institutes, hospitals, and military organizations. In 2021, the academic institutes segment accounted for the largest market share. Also, the same segment is expected to register the highest CAGR from 2022 to 2028.

A patient simulator is a manikin used to train healthcare professionals and students to study human anatomy or function (physiology). Patient simulators can also be combined with computer software, replicating normal and abnormal bodily reactions to events, such as asthma attacks, and therapeutic interventions, including drug side effects. Simulated blood can be pumped into the veins through an intravenous (IV) tube. Patient simulators are life-like manikins that react physiologically like a normal human being. The simulators are specifically designed, keeping respiratory therapy, nursing, and emergency medical students in mind. Additionally, simulation is the only teaching method that provides repeated hands-on experience with real-time feedback in a safe, controlled environment without causing any harm or inconvenience to real patients. The need for simulator training for in-service education of existing healthcare professionals is growing rapidly and has been amplified by the COVID-19 pandemic. A study published by the National Council of State Boards of Nursing (NCSBN) found that training with the simulator is as effective as clinical training with a patient in training nursing students. NCSBN authorized that up to 50% of the students’ clinical time could be done via a simulator in an optimally designed simulation training program. Thus, the growing use of simulators in teaching hospitals, nursing schools, military medical training, and paramedic training centers for training purposes is driving the patient simulators market.

CAE Inc, Laerdal Medical AS, Gaumard Scientific Co Inc, Kyoto Kagaku Co Ltd, Surgical Science Sweden AB, Simulab Corp, Simulaids Ltd, Mentice AB, Limbs & Things Ltd, and VirtaMed AG are among the leading companies operating in the patient simulators market.

In terms of geography, the patient simulators market has been segmented as follows:

Based on geography, the patient simulators market is primarily segmented into North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. The patient simulators market in North America is further segmented into the US, Canada, and Mexico. The European patient simulators market is subsegmented into France, Germany, the UK, Spain, Italy, and the Rest of Europe. The patient simulators market in APAC is segmented into Japan, China, India, Australia, South Korea, and the Rest of APAC. The patient simulators market in the MEA is further segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the MEA. The patient simulators market in South & Central America is further segmented into Brazil, Argentina, and the Rest of South & Central America.